Health-related quality of life in GALAHAD: A multicenter, open-label, phase 2 study of niraparib for patients with metastatic castration-resistant prostate cancer and DNA-repair gene defects

Author:

Smith Matthew R1,Sandhu Shahneen2,George Daniel J3,Chi Kim Nguyen4,Saad Fred5,Thiery-Vuillemin Antoine6,Stàhl Olaf7,Olmos David89,Danila Daniel C10,Gafanov Rustem11,Castro Elena912,Moon Helen13,Joshua Anthony M14,Mason Gary E15,Espina Byron M16,Liu Yan17,Lopez-Gitlitz Angela16,Francis Peter18,Bevans Katherine B17,Fizazi Karim19

Affiliation:

1. Hematology-Oncology Division, Massachusetts General Hospital, Harvard Medical School, Boston.

2. Medical Oncology, Peter MacCallum Cancer Centre and the University of Melbourne, Australia.

3. Medical Oncology, Duke University School of Medicine, Duke Cancer Institute, Durham, NC.

4. Division of Medical Oncology, BC Cancer, University of British Columbia, Vancouver, Canada.

5. Centre Hospitalier de L’université de Montréal, Université de Montréal, Montréal, Québec, Canada.

6. Medical Oncology Department, Centre Hospitalier Régional Universitaire Besancon – Hôpital Jean Minjoz, Besancon, France.

7. Department of Oncology, Skåne University Hospital, Lund, Sweden.

8. Department of Medical Oncology, Spanish National Cancer Research Centre, Madrid, Spain.

9. Genitourinary Cancer Research Unit, Institute of Biomedical Research in Málaga, Spain, now with Hospital Universitario 12 de Octubre, Instituto de Investigación Sanitaria Hospital 12 de Octubre, Madrid, Spain.

10. Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.

11. Medical Oncology, Russian Scientific Center of Roentgenology and Radiology, Moscow.

12. Medical Oncology Department, Hospital Virgen de la Victoria, Málaga, Spain.

13. Hematology-Oncology, Kaiser Permanente Southern California, Riverside.

14. Medical Oncology Department, Kinghorn Cancer Centre, St. Vincent’s Hospital Sydney, Darlinghurst, Australia.

15. Clinical Oncology, Janssen Research & Development, LLC, Spring House, PA.

16. Clinical Oncology, Janssen Research & Development, LLC, Los Angeles, CA.

17. Janssen Global Commercial Strategy Organization, Horsham, PA, now with Genmab US, Plainsboro, NJ.

18. Janssen Research & Development, LLC, Raritan, NJ.

19. Medical Oncology Department, Institut Gustave Roussy, Université Paris-Saclay, Villejuif, France.

Publisher

Academy of Managed Care Pharmacy

Subject

Health Policy,Pharmaceutical Science,Pharmacy

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3